Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial (Q84757114)
Jump to navigation
Jump to search
scientific article published on 08 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial |
scientific article published on 08 August 2012 |
Statements
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial (English)
John A Liu Yin
Michelle A O'Brien
Sarah B Daly
Keith Wheatley